Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles

International Journal of Pharmaceutics

Volumn 511, Issue 1, 2016, Pages 57-64

  Zhang, Yongtai ^a   Li, Zhe ^a   Zhang, Kai ^a   Yang, Gang ^a   Wang, Zhi ^a   Zhao, Jihui ^a   Hu, Rongfeng ^b   Feng, Nianping ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Lipid nanoparticles; Microemulsion; Nanocarrier; Pharmacokinetics; Sustained release

Indexed keywords

FERULIC ACID; GLYCEROL BEHENATE; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; OLEIC ACID ETHYL ESTER; SOLID LIPID NANOPARTICLE; TRANS FERULIC ACID; UNCLASSIFIED DRUG; COUMARIC ACID; DRUG CARRIER; LIPID; NANOMATERIAL; NANOPARTICLE; OLEIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG RETENTION; DRUG STABILITY; DRUG STORAGE; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MICROEMULSION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; ANIMAL; BIOAVAILABILITY; COMPARATIVE STUDY; DRUG EFFECTS; GASTROINTESTINAL TRACT; METABOLISM; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; COUMARIC ACIDS; DRUG CARRIERS; GASTROINTESTINAL TRACT; LIPIDS; MALE; NANOPARTICLES; NANOSTRUCTURES; OLEIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84978238250     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2016.06.131     Document Type: Article

References (37)

1. Aburahma, M.H., Badr-Eldin, S.M., Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin. Drug Deliv. 11 (2014), 1865–1883.
2. Andrade, L.M., de Fátima Reis, C., Maione-Silva, L., Anjos, J.L., Alonso, A., Serpa, R.C., Marreto, R.N., Lima, E.M., Taveira, S.F., Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Eur. J. Pharm. Biopharm. 88 (2014), 40–47.
3. Apaolaza, P.S., Del Pozo-Rodríguez, A., Torrecilla, J., Rodríguez-Gascón, A., Rodríguez, J.M., Friedrich, U., Weber, B.H., Solinís, M.A., Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: in vivo approaches in Rs1h-deficient mouse model. J. Control. Release 217 (2015), 273–283.
4. Barone, E., Calabrese, V., Mancuso, C., Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontology 10 (2009), 97–108.
5. Battani, S., Pawar, H., Suresh, S., Evaluation of oral bioavailability and anticancer potential of raloxifene solid lipid nanoparticles. J. Nanosci. Nanotechnol. 14 (2014), 5638–5645.
6. Beloqui, A., Solinís, M.Á., Delgado, A., Evora, C., Isla, A., Rodríguez-Gascón, A., Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution. J. Microencapsul. 31 (2014), 1–8.
7. Beloqui, A., Á. Solinís, M., Rodríguez-Gascón, A., Almeida, A.J., Préat, V., Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomedicine 12 (2016), 143–161.
8. Calixto, G., Bernegossi, J., Fonseca-Santos, B., Chorilli, M., Nanotechnology-based drug delivery systems for treatment of oral cancer: a review. Int. J. Nanomed. 9 (2014), 3719–3735.
9. Carbone, C., Campisi, A., Musumeci, T., Raciti, G., Bonfanti, R., Puglisi, G., FA-loaded lipid drug delivery systems: preparation, characterization and biological studies. Eur. J. Pharm. Sci. 52 (2014), 12–20.
10. Cassano, R., Trombino, S., Cilea, A., Ferrarelli, T., Muzzalupo, R., Picci, N., L-lysine pro-prodrug containing trans-ferulic acid for 5-amino salicylic acid colon delivery: synthesis, characterization and in vitro antioxidant activity evaluation. Chem. Pharm. Bull. (Tokyo) 58 (2010), 103–105.
11. Chotimarkorn, C., Ushio, H., The effect of trans-ferulic acid and gamma-oryzanol on ethanol-induced liver injury in C57BL mouse. Phytomedicine 15 (2008), 951–958.
12. Cipolla, D., Shekunov, B., Blanchard, J., Hickey, A., Lipid-based carriers for pulmonary products: preclinical development and case studies in humans. Adv. Drug Deliv. Rev. 75 (2014), 53–80.
13. Fang, G., Tang, B., Chao, Y., Xu, H., Gou, J., Zhang, Y., Xu, H., Tang, X., Cysteine-functionalized nanostructured lipid carriers for oral delivery of docetaxel: a permeability and pharmacokinetic study. Mol. Pharm. 12 (2015), 2384–2395.
14. Hou, C., Shi, X., Wang, H., An, N., Measurement and correlation of solubilities of trans-ferulic acid in solvents. J. Chem. Ind. Eng. (China) 58 (2007), 2705–2709.
15. Hu, X., Zhang, J., Yu, Z., Xie, Y., He, H., Qi, J., Dong, X., Lu, Y., Zhao, W., Wu, W., Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers. Nanomedicine 11 (2015), 1939–1948.
16. Hu, X., Fan, W., Yu, Z., Lu, Y., Qi, J., Zhang, J., Dong, X., Zhao, W., Wu, W., Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery. Nanoscale 8 (2016), 7024–7035.
17. Kolenyak-Santos, F., Garnero, C., de Oliveira, R.N., de Souza, A.L., Chorilli, M., Allegretti, S.M., Longhi, M.R., Chaud, M.V., Gremião, M.P., Nanostructured lipid carriers as a strategy to improve the in vitro schistosomiasis activity of praziquantel. J. Nanosci. Nanotechnol. 15 (2015), 761–772.
18. Lancelot, A., Sierra, T., Serrano, J.L., Nanostructured liquid-crystalline particles for drug delivery. Expert Opin. Drug Deliv. 11 (2014), 547–564.
19. Lin, C., Chen, F., Ye, T., Zhang, L., Zhang, W., Liu, D., Xiong, W., Yang, X., Pan, W., A novel oral delivery system consisting in drug-in cyclodextrin-in nanostructured lipid carriers for poorly water-soluble drug: vinpocetine. Int. J. Pharm. 465 (2014), 90–96.
20. Makwana, V., Jain, R., Patel, K., Nivsarkar, M., Joshi, A., Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach. Int. J. Pharm. 495 (2015), 439–446.
21. Muchow, M., Maincent, P., Muller, R.H., Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev. Ind. Pharm. 34 (2008), 1394–1405.
22. Nguyen, H.M., Hwang, I.C., Park, J.W., Park, H.J., Enhanced payload and photo-protection for pesticides using nanostructured lipid carriers with corn oil as liquid lipid. J. Microencapsul. 29 (2012), 596–604.
23. Niu, M., Tan, Y., Guan, P., Hovgaard, L., Lu, Y., Qi, J., Lian, R., Li, X., Wu, W., Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study. Int. J. Pharm. 460 (2014), 119–130.
24. Pouton, C.W., Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur. J. Pharm. Sci. 11:Suppl. 2 (2000), S93–S98.
25. Qi, R., Li, Y.Z., Chen, C., Cao, Y.N., Yu, M.M., Xu, L., He, B., Jie, X., Shen, W.W., Wang, Y.N., van Dongen, M.A., Liu, G.Q., BanaszakHoll, M.M., Zhang, Q., Ke, X., G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. J. Control. Release 210 (2015), 160–168.
26. Ren, Q., Deng, C., Meng, L., Chen, Y., Chen, L., Sha, X., Fang, X., In vitro, ex vivo, and in vivo evaluation of the effect of saturated fat acid chain length on the transdermal behavior of ibuprofen-loaded microemulsions. J. Pharm. Sci. 103 (2014), 1680–1691.
27. Serpe, L., Canaparo, R., Daperno, M., Sostegni, R., Martinasso, G., Muntoni, E., Ippolito, L., Vivenza, N., Pera, A., Eandi, M., Gasco, M.R., Zara, G.P., Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole-blood model. Eur. J. Pharm. Sci. 39 (2010), 428–436.
28. Shah, N.H., Teresa Carvajal, M., Patel, C.I., Infeld, M.H., Malick, A.W., Self-Emulsifying drug delivery systems (SEDDS) for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 106 (1994), 15–23.
29. Shen, L.N., Zhang, Y.T., Wang, Q., Xu, L., Feng, N.P., Preparation and evaluation of microemulsion-based transdermal delivery of total flavone of rhizoma arisaematis. Int. J. Nanomed. 9 (2014), 3453–3464.
30. Shete, H.K., Selkar, N., Vanage, G.R., Patravale, V.B., Tamoxifen nanostructured lipid carriers: enhanced in vivo antitumor efficacy with reduced adverse drug effects. Int. J. Pharm. 468 (2014), 1–14.
31. Trombino, S., Cassano, R., Ferrarelli, T., Barone, E., Picci, N., Mancuso, C., Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf. B Biointerfaces 109 (2013), 273–279.
32. Wang, J., Wang, H., Zhu, R., Liu, Q., Fei, J., Wang, S., Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis. Biomaterials 53 (2015), 475–483.
33. Wosicka-Frąckowiak, H., Cal, K., Stefanowska, J., Główka, E., Nowacka, M., Struck-Lewicka, W., Govedarica, B., Pasikowska, M., Dębowska, R., Jesionowski, T., Srčič, S., Markuszewski, M.J., Roxithromycin-loaded lipid nanoparticles for follicular targeting. Int. J. Pharm. 495 (2015), 807–815.
34. Yu, Q., Hu, X., Ma, Y., Xie, Y., Lu, Y., Qi, J., Xiang, L., Li, F., Wu, W., Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus. Drug Deliv. 23 (2016), 1469–1475.
35. Zhang, C., Peng, F., Liu, W., Wan, J., Wan, C., Xu, H., Lam, C.W., Yang, X., Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats. Int. J. Nanomed. 9 (2014), 1049–1063.
36. Zhang, Y.T., Wu, Z.H., Zhang, K., Zhao, J.H., Ye, B.N., Feng, N.P., An in vitro and in vivo comparison of solid and liquid-oil cores in transdermal aconitine nanocarriers. J. Pharm. Sci. 103 (2014), 3602–3610.
37. Zhang, Y.T., Zhao, J.H., Zhang, S.J., Zhong, Y.Z., Wang, Z., Liu, Y., Shi, F., Feng, N.P., Enhanced transdermal delivery of evodiamine and rutaecarpine using microemulsion. Int. J. Nanomed. 6 (2011), 2469–2482.